This article demonstrates the potential of traditional chinese medicine to improve end-of-life care in elderly cancer patients, highlighting ethical considerations.
The combined effects of a rapidly aging global population and high mortality rates from malignant tumors have pushed end-of-life care for elderly cancer patients to the forefront of the public health agenda. Current symptom-drug-focused intervention models face structural gaps in multidimensional psychosocial care, cultural accessibility, and family support, triggering an urgent need for non-pharmacological, minimally invasive, and locally relevant integrated solutions. This article focuses on evidence-based practice and ethical innovations in Traditional Chinese Medicine (TCM) for end-of-life care for elderly cancer patients. Topical TCM applications leverage a transdermal mechanism of "treating internal illness externally" to simultaneously alleviate cancer pain and reduce opioid dependence; Five Elements music therapy reshapes emotional homeostasis through the resonance of the five tones and the five internal organs; and TCM emotional care focuses on soothing the liver and relieving depression, fostering a collaborative patient-family support network. Current bottlenecks lie in the dual lack of high-quality evidence and a localized ethical framework. Future approaches require integrating TCM's philosophy of benevolence with modern bioethics to construct new approaches to end-of-life care that combine cultural subjectivity with global compatibility.
No takes yet. Share an insight, caveat, or question.
Shiyu Huang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: